X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8264) 8264
Book Review (969) 969
Publication (208) 208
Magazine Article (19) 19
Book Chapter (17) 17
Newsletter (12) 12
Conference Proceeding (10) 10
Book / eBook (5) 5
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7585) 7585
humans (5745) 5745
verapamil - therapeutic use (4229) 4229
male (4051) 4051
female (3115) 3115
verapamil (2950) 2950
animals (2595) 2595
middle aged (2418) 2418
adult (2096) 2096
verapamil - pharmacology (2053) 2053
pharmacology & pharmacy (1714) 1714
aged (1561) 1561
abridged index medicus (1343) 1343
calcium channel blockers - therapeutic use (1306) 1306
rats (1059) 1059
verapamil - administration & dosage (1033) 1033
cardiac & cardiovascular systems (882) 882
hypertension - drug therapy (881) 881
electrocardiography (874) 874
calcium channel blockers - pharmacology (829) 829
blood pressure - drug effects (746) 746
heart rate - drug effects (641) 641
dose-response relationship, drug (616) 616
p-glycoprotein (612) 612
drug therapy, combination (605) 605
anti-arrhythmia agents - therapeutic use (592) 592
nifedipine - therapeutic use (589) 589
time factors (569) 569
verapamil - adverse effects (540) 540
in vitro techniques (472) 472
angina pectoris - drug therapy (469) 469
double-blind method (469) 469
adolescent (459) 459
hemodynamics - drug effects (459) 459
nifedipine (456) 456
diltiazem - therapeutic use (449) 449
mice (443) 443
treatment outcome (434) 434
drug interactions (409) 409
clinical trials as topic (406) 406
dogs (389) 389
hypertension (380) 380
calcium (375) 375
diltiazem (374) 374
vasodilator agents - therapeutic use (354) 354
calcium - metabolism (347) 347
arrhythmias, cardiac - drug therapy (346) 346
drug resistance (345) 345
nifedipine - pharmacology (333) 333
propranolol - therapeutic use (328) 328
coronary disease - drug therapy (310) 310
hypertension - physiopathology (309) 309
adrenergic beta-antagonists - therapeutic use (306) 306
atrial fibrillation - drug therapy (301) 301
antihypertensive agents - therapeutic use (296) 296
administration, oral (295) 295
drug therapy (293) 293
myocardial contraction - drug effects (288) 288
heart - drug effects (286) 286
calcium channel blockers - administration & dosage (285) 285
oncology (284) 284
pharmacokinetics (284) 284
drugs (270) 270
medicine, general & internal (270) 270
expression (263) 263
tachycardia - drug therapy (263) 263
toxicology (259) 259
analysis (258) 258
diltiazem - pharmacology (254) 254
calcium channel blockers (253) 253
injections, intravenous (251) 251
rabbits (250) 250
rats, sprague-dawley (250) 250
myocardial infarction - drug therapy (248) 248
rats, wistar (248) 248
exercise test (240) 240
therapy (234) 234
atp-binding cassette, sub-family b, member 1 - metabolism (232) 232
verapamil - pharmacokinetics (230) 230
child (229) 229
prospective studies (229) 229
inhibition (226) 226
delayed-action preparations (221) 221
follow-up studies (219) 219
kinetics (219) 219
multidrug-resistance (217) 217
rats, inbred strains (217) 217
peripheral vascular disease (216) 216
multidrug resistance (215) 215
myocardium - metabolism (211) 211
calcium channel blockers - adverse effects (210) 210
electrophysiology (207) 207
cells (206) 206
drug synergism (204) 204
in-vitro (199) 199
blood pressure (197) 197
drug evaluation (196) 196
health aspects (196) 196
aged, 80 and over (194) 194
care and treatment (193) 193
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7024) 7024
German (293) 293
Russian (278) 278
Italian (179) 179
French (122) 122
Portuguese (79) 79
Spanish (68) 68
Japanese (63) 63
Polish (60) 60
Chinese (46) 46
Czech (19) 19
Danish (16) 16
Hebrew (13) 13
Hungarian (11) 11
Bulgarian (9) 9
Dutch (6) 6
Romanian (6) 6
Swedish (6) 6
Finnish (5) 5
Norwegian (4) 4
Serbian (4) 4
Croatian (3) 3
Ukrainian (3) 3
Slovak (2) 2
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1992, 1st ed., Experts in dialogue, ISBN 3926774177, Volume 18, 223
Book
Congenital Heart Disease, ISSN 1747-079X, 01/2013, Volume 8, Issue 1, pp. 48 - 56
Objectives.  The current drug of choice for reentrant supraventricular tachycardia (SVT) is adenosine followed by verapamil or diltiazem. Although limitations... 
Cardioversion | Supraventricular Tachycardia | Adenosine | Adrenergic Agonists | Arrhythmias | Dexmedetomidine | Adrenergic agonists | Supraventricular tachycardia | EMERGENCY | TACHYARRHYTHMIAS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | ATRIAL | CONGENITAL CARDIAC-SURGERY | CHILDREN | NUCLEUS | INFANTS | VERAPAMIL | Usage | Cardiac patients | Sympathomimetic agents | Children | Diltiazem | Health aspects
Journal Article
JAMA, ISSN 0098-7484, 12/2003, Volume 290, Issue 21, pp. 2805 - 2816
Journal Article
JAMA, ISSN 0098-7484, 04/2003, Volume 289, Issue 16, pp. 2073 - 2082
Journal Article
Cancer Cell, ISSN 1535-6108, 01/2015, Volume 27, Issue 1, pp. 123 - 137
Journal Article
Journal Article
European Journal of Haematology, ISSN 0902-4441, 06/2012, Volume 88, Issue 6, pp. 535 - 548
Objectives:  Iron‐overload cardiomyopathy is a major cause of morbidity and mortality in patients with thalassemia. However, the precise mechanisms of iron... 
calcium channel | iron overload | cardiac iron | left ventricular function | heart rate variability | Iron overload | Cardiac iron | Calcium channel | Heart rate variability | Left ventricular function | MALONDIALDEHYDE | QUANTIFICATION | CA2+ CHANNELS | CARDIAC MYOCYTES | RATS | CARDIOMYOCYTES | TRANSFERRIN-BOUND IRON | HEART-RATE-VARIABILITY | IRON-OVERLOAD CARDIOMYOPATHY | HEMATOLOGY | EXPRESSION | beta-Thalassemia - pathology | Humans | Calcium Channel Blockers - therapeutic use | beta-Thalassemia - genetics | Deferoxamine - therapeutic use | Azoles - therapeutic use | DNA Primers - genetics | Iron, Dietary - administration & dosage | RNA, Messenger - metabolism | Cardiovascular System - physiopathology | Verapamil - therapeutic use | Base Sequence | Nifedipine - therapeutic use | Nitrophenols - therapeutic use | Calcium Channels, T-Type - genetics | Organoselenium Compounds - therapeutic use | Disease Models, Animal | Iron - blood | Heart Rate | Iron Chelating Agents - therapeutic use | Mice, Inbred C57BL | RNA, Messenger - genetics | Ventricular Function, Left - drug effects | Organophosphorus Compounds - therapeutic use | beta-Thalassemia - physiopathology | Cardiovascular System - drug effects | Iron - metabolism | Mice, Knockout | Dihydropyridines - therapeutic use | beta-Thalassemia - drug therapy | Organ Size - drug effects | Animals | Calcium Channels, L-Type - genetics | Calcium Channels, L-Type - drug effects | Calcium Channels, T-Type - drug effects | Mice | Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2004, Volume 351, Issue 19, pp. 1941 - 1951
Journal Article
Journal Article
Journal Article
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2007, Volume 120, Issue 10, pp. 863 - 870
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 06/2006, Volume 144, Issue 12, pp. 884 - 893
Background: Because coronary perfusion occurs mainly during diastole, patients with coronary artery disease (CAD) could be at increased risk for coronary... 
Myocardial Infarction - epidemiology | Diastole | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Hypertension - drug therapy | Male | Treatment Outcome | Antihypertensive Agents - therapeutic use |